That is not dead which can eternal lie, and with strange aeons bring us some web forums whereupon we can gather
http://octopusoverlords.com/forum/
Easy peasy but finding time where I can be knocked out for a few days is not. Last time I booked at CVS for the next day. However, I'm trying to train a new guy to take over my work life and he's still lost on his own after a week. At the same time, I want my shot in arm and immunity raised before 13th of next month when I predict the next local super spreading weekend will start the next chain of ugliness.Ralph-Wiggum wrote: ↑Mon Feb 14, 2022 4:03 pm I just did mine through Walgreens's website without going through a doctor. It asked a few questions and then showed me available times. Easy peasy.
I've been seeing comments to the effect that there are vaccine skeptics that won't take the mRNA vaccines but will be willing to take the Novavax vaccine. This strikes me as an optimistic take.Novavax's COVID-19 vaccine has been approved for use in Canadians age 18 and older by Health Canada.
The approval of the vaccine, known as Nuvaxovid, comes about 18 months after the federal government announced a deal to produce batches of it in Montreal.
Health Canada is recommending the interval for the two-dose vaccine to be at least 21 days based on evidence from clinical trials.
Chief Public Health Officer Dr. Theresa Tam said at a briefing Thursday the first Nuvaxovid delivery is expected in March, arriving from India's Serum Institute. Federal officials said they weren't able to provide any clarity on the size or schedule of the deliveries.
Trial data involving about 45,000 people in multiple countries suggests the vaccine is more than 90 per cent effective in preventing severe illness and death.
The trials conducted by Novavax as part of its regulatory filing took place when the Alpha variant of the coronavirus was predominant, and Health Canada says Novavax will be "required to provide data regarding protection against current and emerging variants of concern, when available."
Novavax has conducted trials of its vaccine for use in teens when Delta was the dominant variant but has not yet filed for authorization for younger age groups.
Health Canada's chief medical adviser, Dr. Supriya Sharma, said that the company had also submitted lab-based studies that, while "imperfect" compared to clinical trials, show that neutralizing antibodies are formed by the vaccine for Omicron variant infections.
that excuse is so one year ago. they've fully bought into the antivax tribal membership now.
They (vaccine manufacturers) are currently looking at data to see if one will be recommended for everyone in the Fall of 2022 - similar to the annual flu shot. Given what's been happening and the continued refusal to do anything proactive to stop spread, I'd say it feels likely.
It's not exactly the same because COVID-19 immunity for the unvaccinated isn't the same as post-vaccination immunity (especially true for those that had Omicron), but it certainly is an interesting way to think about where this is headed next (as people continue to yell about their "natural immunity" and how forcing them to do anything vaccine or mask related is unfair).However, what happens after this drop in incidence can be complicated. It is known that some diseases exhibit "honeymoon periods" (long periods of temporary low disease incidence after start of mass vaccination). These periods end with a natural resurgence of the disease, which is not due to any change in the system.
From the bleacher seats, I'm inclined to doubt it. Warm days/Cold nights bars and spring break are around the corner and I'm seeing round two dummies happening. Three (unvaxxed and can't be bothered to hygiene because natural antibodies) people in my office got taken down in one week for their second COVacation and if none of the experience long COVID you can expect they'll remain in the it's just flu pool.Smoove_B wrote: ↑Mon Feb 21, 2022 10:26 am I also don't know if it's just coming up in my circles or if it's actually making it out into mass-media, but I've been seeing lots of my people talking about how we're in a type of post-Omicron honeymoon period that has resulted from a mixed state of vaccinated and recently exposed people.
Medicago's plant-based COVID-19 vaccine is now approved by Health Canada, which will soon give Canadians the option of getting a homegrown shot against SARS-CoV-2.
Regulators announced the decision to allow its use for adults 18 to 64 years of age on Thursday, making this the sixth vaccine approved in Canada, on the heels of Health Canada's approval of the Novavax shot last week.
In what the biopharmaceutical company calls a world first, the vaccine from Quebec City-based Medicago uses plant-derived, virus-like particles, which resemble the coronavirus behind COVID-19 but don't contain its genetic material.
The shots also contain an adjuvant from British-American vaccine giant GlaxoSmithKline to help boost the immune response.
In December, the companies reported high efficacy levels against infection as they geared up for regulatory approval.
Dubbed "Covifenz," the two-dose shot's overall efficacy rate against all virus variants studied was 71 per cent, with a higher efficacy rate of 75 per cent against COVID-19 infections of any severity from the delta variant, then dominant, according to data shared at the time in a press release.
The results followed a global, Phase 3, placebo-controlled study of the two-dose vaccine that was launched last March. This was before the highly contagious Omicron family of subvariants, including BA.1 and BA.2, began circulating, though the company has said the vaccine can be adapted as needed.
"While additional confirmatory data are needed, preliminary and exploratory data shows that Covifenz produces neutralizing antibodies against the Omicron variant," noted Health Canada in a statement.
told my mom about this, and three hours later, she got a notification from her clinic saying she was eligible for this in the future. (she got a sotrovimab infusion in January)MHS wrote: ↑Thu Mar 10, 2022 11:46 am Today I got scheduled for my first Evusheld dose, although I won't actually get the injection until mid-April. I wasn't even aware of this until a co-worker sent me an article last weekend.
Some important numbers around this: studies have found that because the immunocompromised don't produce sufficient antibodies even with our vaccinations and boosters, we are 485 times more likely to die or be hospitalized with severe infections if we get breakthrough covid, and this drug supposedly is 77% more effective in reducing the risk. Pass the word if you know people who could benefit from this.
https://abc7.com/covid-19-medical-treat ... /11630608/
Glad to see they're on top of things! My nephrology team didn't say squat to me about sotrovimab OR Evusheld...I had to ask for it.hitbyambulance wrote: ↑Thu Mar 10, 2022 6:07 pmtold my mom about this, and three hours later, she got a notification from her clinic saying she was eligible for this in the future. (she got a sotrovimab infusion in January)MHS wrote: ↑Thu Mar 10, 2022 11:46 am Today I got scheduled for my first Evusheld dose, although I won't actually get the injection until mid-April. I wasn't even aware of this until a co-worker sent me an article last weekend.
Some important numbers around this: studies have found that because the immunocompromised don't produce sufficient antibodies even with our vaccinations and boosters, we are 485 times more likely to die or be hospitalized with severe infections if we get breakthrough covid, and this drug supposedly is 77% more effective in reducing the risk. Pass the word if you know people who could benefit from this.
https://abc7.com/covid-19-medical-treat ... /11630608/
And here I was expecting that a plant-sourced vaccine would the the least ethically compromised option possible.The World Health Organization has decided not to accept Quebec's Medicago COVID-19 vaccine for emergency use, citing the company's ties to big tobacco.
The decision was anticipated, as the WHO paused the process for pre-qualification of the company's new Covifenz shot last week. Marlboro cigarette manufacturer, Philip Morris International, is a shareholder of the Quebec City-based company.
In a statement to CBC News on Friday, the WHO said the company's request for emergency use listing of its vaccine was not accepted, effectively keeping it out of the COVID-19 Vaccines Global Access (COVAX) program, a global vaccine-sharing initiative.
Medicago says it received an email with WHO's "preliminary decision" and is awaiting additional information, at which point the company will discuss next steps with its partners and shareholders to get the vaccine to market.
"It is our understanding that this decision is linked to Medicago's minority shareholder and not the demonstrated safety and efficacy profile of our COVID-19 vaccine," said president and CEO Takashi Nagao in a statement Friday.
Philip Morris Investments, a subsidiary of the tobacco giant, currently holds approximately 21 per cent of the company's shares.
It makes sense but we're still not going to booster our way out of this. So many people still haven't (and won't) get a 3rd shot, so this just continues to complicate things.The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster.
Until now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems. The agency said this especially fragile group also can get an additional booster, a fifth shot.
The latest expansion, regardless of people’s health, allows an extra shot to millions more Americans — and the question is whether everyone who’s eligible should rush out and get it. The Centers for Disease Control and Prevention is expected to weigh in.
I'm going to hold off on that until transmission rises again, rather than "waste" the immunity boost while it's still very low.Smoove_B wrote: ↑Tue Mar 29, 2022 11:58 am FDA authorize 2nd booster for people over 50:
It makes sense but we're still not going to booster our way out of this. So many people still haven't (and won't) get a 3rd shot, so this just continues to complicate things.The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster.
Until now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems. The agency said this especially fragile group also can get an additional booster, a fifth shot.
The latest expansion, regardless of people’s health, allows an extra shot to millions more Americans — and the question is whether everyone who’s eligible should rush out and get it. The Centers for Disease Control and Prevention is expected to weigh in.
Add another (likely significant) percentage that were infected and never knew it. My own son's case would never have been detected or even suspected if he hadn't had to take a COVID test for a medical procedure.
Assuming they recommend a fifth shot for the immunosuppressed eventually, I'll wait until late August for that same reason. I was happy to get my 4th when I did, even if it turns out that I'm wrong and spread isn't going up right now. I'm looking forward to being wrong (signs point to me being wrong) and feeling like I can relax a bit as we move in to mid April. The first time I get out of my car and forget my mask and say "fuck it" or go to a restaurant indoors and stay for a bit and chat after the meal is concluded or heaven forbid have an alcoholic beverage. Soon... Sooooon....Kraken wrote: ↑Tue Mar 29, 2022 4:11 pmI'm going to hold off on that until transmission rises again, rather than "waste" the immunity boost while it's still very low.Smoove_B wrote: ↑Tue Mar 29, 2022 11:58 am FDA authorize 2nd booster for people over 50:
It makes sense but we're still not going to booster our way out of this. So many people still haven't (and won't) get a 3rd shot, so this just continues to complicate things.The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster.
Until now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems. The agency said this especially fragile group also can get an additional booster, a fifth shot.
The latest expansion, regardless of people’s health, allows an extra shot to millions more Americans — and the question is whether everyone who’s eligible should rush out and get it. The Centers for Disease Control and Prevention is expected to weigh in.
We started dining out once a week again just a few weeks ago, and we might have to shut that down again a few weeks from now. Wastewater virus counts are rising here, although they're still reasonably low, and the positive test rate is back over 2%. My trigger level is 3%. So the trend is going in the wrong direction but we also have the seasons on our side. Fauci says we should expect a surge, but not a major one.LordMortis wrote: ↑Wed Mar 30, 2022 11:12 amAssuming they recommend a fifth shot for the immunosuppressed eventually, I'll wait until late August for that same reason. I was happy to get my 4th when I did, even if it turns out that I'm wrong and spread isn't going up right now. I'm looking forward to being wrong (signs point to me being wrong) and feeling like I can relax a bit as we move in to mid April. The first time I get out of my car and forget my mask and say "fuck it" or go to a restaurant indoors and stay for a bit and chat after the meal is concluded or heaven forbid have an alcoholic beverage. Soon... Sooooon....Kraken wrote: ↑Tue Mar 29, 2022 4:11 pmI'm going to hold off on that until transmission rises again, rather than "waste" the immunity boost while it's still very low.Smoove_B wrote: ↑Tue Mar 29, 2022 11:58 am FDA authorize 2nd booster for people over 50:
It makes sense but we're still not going to booster our way out of this. So many people still haven't (and won't) get a 3rd shot, so this just continues to complicate things.The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to that age group at least four months after their previous booster.
Until now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems. The agency said this especially fragile group also can get an additional booster, a fifth shot.
The latest expansion, regardless of people’s health, allows an extra shot to millions more Americans — and the question is whether everyone who’s eligible should rush out and get it. The Centers for Disease Control and Prevention is expected to weigh in.
Ontario is reporting 778 people hospitalized with COVID-19 Wednesday as health experts are cautioning people to keep wearing masks as the province sees a rise in hospital occupancy in the wake of public health measures being lifted.
Dr. Peter Jüni, head of Ontario's COVID-19 science advisory table, says the province is seeing the effect of easing of public health measures in the past few weeks — including the lifting of mask mandates in most settings and the end of gathering limits.
"We're seeing quite the steep increase right now in wastewater predominantly, and it starts to be followed now by an increase in hospital occupancy," Jüni told CBC News Wednesday morning.
"We are in the middle of it, however we call it. It's either the resurgence expected after the reopening of the last wave or you can call it the sixth wave."
Predictably, no mention from the government to the effect that maybe people should wear masks where appropriate, although individual researchers, doctors, etc are advising that people do so.In a statement to CBC News Wednesday, the Ministry of Health said the province's Chief Medical Officer of Health, Dr. Kieran Moore, will continue to monitor the data and evidence on an "ongoing basis.
"As Dr. Moore has previously said, indicators are expected to rise as Ontarians increasingly interact with one another. However, thanks to our high vaccination rates and natural immunity, as well as the arrival of antivirals, Ontario has the tools necessary to manage the impact of the virus," the statement reads.